Volume 20, Issue 1 , Pages 131-144, February 2006
Do intra-articular therapies work and who will benefit most?
The main intra-articular (IA) treatments used in osteoarthritis are corticosteroids and hyaluronan injections. Data concerning their short- and long-term efficacy and their potential side-effects are reviewed here. IA corticosteroids are effective for reducing short-term pain and appear to have no long-term deleterious effects on the cartilage; they may be more efficacious in patients with joint effusion and/or symptom flares. IA hyaluronan have a modest but long-lived symptomatic effect on pain and functional outcome in knee osteoarthritis; the level of evidence is poor concerning their efficacy in other joints. The differences in efficacy related to the molecular weight of the hyaluronan are a subject of debate. There is a risk of acute painful reactions, which seem more frequent with higher-molecular-weight hyaluronan. Some data—mainly from animal studies—suggest a possible long-term chondroprotective effect of hyaluronan. This treatment seems more efficacious in non-radiologically severe osteoarthritis with no or mild effusion.
Key words: osteoarthritis, hyaluronan, corticosteroids, intra-articular, symptomatic, pain, function, review
To access this article, please choose from the options below
PII: S1521-6942(05)00105-1
doi:10.1016/j.berh.2005.09.005
© 2005 Elsevier Ltd. All rights reserved.
Volume 20, Issue 1 , Pages 131-144, February 2006
